Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)

American Heart Journal

Volumn 164, Issue 3, 2012, Pages 285-291

  Mathiasen, Anders Bruun ^a   Jorgensen, Erik ^a   Qayyum, Abbas Ali ^a   Haack Sorensen, Mandana ^a   Ekblond, Annette ^a   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTICLE; BONE MARROW BIOPSY; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CAUSE OF DEATH; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART TAMPONADE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCAR; SHORT COURSE THERAPY; STROKE; SYMPTOM; TREATMENT OUTCOME;

BONE MARROW CELLS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INJECTIONS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; RESEARCH DESIGN; STROKE VOLUME; SYSTOLE; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84866325647     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.05.026     Document Type: Article

References (35)

1. V.L. Roger, S.A. Weston, and M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350 (Pubitemid 38944258)
2. A.B. Mathiasen, M. Haack-Sorensen, and J. Kastrup Mesenchymal stromal cells for cardiovascular repair: current status and future challenges Future Cardiol 5 2009 605 617
3. M. Haack-Sorensen, T. Friis, and L. Bindslev Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy Scand J Clin Lab Invest 68 2008 192 203
4. S.L. Chen, W.W. Fang, and F. Ye Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction Am J Cardiol 94 2004 92 95 (Pubitemid 38813459)
5. D.G. Katritsis, P.A. Sotiropoulou, and E. Karvouni Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium Catheter Cardiovasc Interv 65 2005 321 329 (Pubitemid 40898172)
6. S. Chen, Z. Liu, and N. Tian Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery J Invasive Cardiol 18 2006 552 556 (Pubitemid 44704523)
7. D.G. Katritsis, P. Sotiropoulou, and E. Giazitzoglou Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells Europace 9 2007 167 171 (Pubitemid 46404162)
8. J.M. Hare, J.H. Traverse, and T.D. Henry A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
9. T. Friis, M. Haack-Sorensen, and A.B. Mathiasen Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina Scand Cardiovasc J 45 2011 161 168
10. M. Haack-Sorensen, T. Friis, and A.B. Mathiasen Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up Cell Transplant 2012
11. J.H. Houtgraaf, W.K. den Dekker, and B.M. van Dalen First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 5 2012 539 540
12. E.C. Perin, H.F. Dohmann, and R. Borojevic Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy Circulation 110 11 Suppl 1 2004 II213 II218
13. B. Assmus, J. Honold, and V. Schachinger Transcoronary transplantation of progenitor cells after myocardial infarction N Engl J Med 355 2006 1222 1232 (Pubitemid 44427446)
14. S.L. Beeres, J.J. Bax, and P. Dibbets-Schneider Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction Am J Cardiol 100 2007 1094 1098 (Pubitemid 47404464)
15. A.C. Diederichsen, J.E. Moller, and P. Thayssen Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study - congestive heart failure trial (DanCell-CHF) Eur J Heart Fail 10 2008 661 667
16. P. Menasche, O. Alfieri, and S. Janssens The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200 (Pubitemid 351552018)
17. N. Dib, J. Dinsmore, and Z. Lababidi One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study) JACC Cardiovasc Interv 2 2009 9 16
18. B.E. Strauer, M. Yousef, and C.M. Schannwell The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study Eur J Heart Fail 12 2010 721 729
19. E.C. Perin, G.V. Silva, and T.D. Henry A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF) Am Heart J 161 2011 1078 1087
20. H.J. Duckers, J. Houtgraaf, and C. Hehrlein Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial EuroIntervention 6 2011 805 812
21. T.J. Povsic, C.M. O'Connor, and T. Henry A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction Am Heart J 162 2011 654 662
22. M. Dominici, B.K. Le, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317 (Pubitemid 44269669)
23. F. Baldazzi, E. Jorgensen, and R.S. Ripa Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route Eur Heart J 29 2008 1819 1826
24. J. Kastrup, E. Jorgensen, and A. Ruck Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 2005 982 988 (Pubitemid 40432426)
25. R.S. Ripa, Y. Wang, and E. Jorgensen Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease Eur Heart J 27 2006 1785 1792 (Pubitemid 44297382)
26. E.C. Perin, G.V. Silva, and Y. Zheng Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure Am Heart J 163 3 2012 415 421 421
27. L.M. de Macedo Braga, S. Lacchini, and B.D. Schaan In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction J Biomed Sci 15 2008 365 374
28. M. Mazo, J.J. Gavira, and G. Abizanda Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat Cell Transplant 19 2010 313 328
29. A. Stolzing, E. Jones, and D. McGonagle Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies Mech Ageing Dev 129 2008 163 173
30. S. Zhou, J.S. Greenberger, and M.W. Epperly Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts Aging Cell 7 2008 335 343 (Pubitemid 351663902)
31. T. Friis, M. Haack-Sorensen, and S.K. Hansen Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease Scand J Clin Lab Invest 71 2011 193 202
32. D.M. Leistner, U. Fischer-Rasokat, and J. Honold Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy Clin Res Cardiol 100 2011 925 934
33. C. Bearzi, M. Rota, and T. Hosoda Human cardiac stem cells Proc Natl Acad Sci USA 104 2007 14068 14073 (Pubitemid 350003336)
34. T. Freyman, G. Polin, and H. Osman A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur Heart J 27 2006 1114 1122
35. E.C. Perin, G.V. Silva, and J.A. Assad Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction J Mol Cell Cardiol 44 2008 486 495 (Pubitemid 351374698)